Sex: F
Vaccine: DTPPVHBHPB, RV5, DTPPVHBHPB, RV5
Symptoms: Extra dose administered, Product dose omission issue
Clinical narrative: On 27-APR-2023, she was vaccinated with rotavirus vaccine and Vaxelis. On 11-MAY-2023, the patient was accidentally vaccinated with another dose of rotavirus vaccine and Vaxelis was accidentally administered another dose of VAXELIS and ROTATE; On 27-APR-2023, she was vaccinated with rotavirus vaccine and Vaxelis. On 11-MAY-2023, the patient was accidentally vaccinated with another dose of rotavirus vaccine and Vaxelis was accidentally administered another dose of VAXELIS and ROTATE; This non-serious case was received during the Vaccines Adverse Event Reporting System (VAERS) monitoring on 12-JUL-2023 with the following VAERS Primary ID 2633240-1. The original narrative from the sender is the following:  the patient has not experienced any adverse reactions associated with the administrations; the patient was accidently administered another dose of VAXELIS and ROTATEQ.; a patient missed her 4 month well child visit to receive her VA and ROTATEQ vaccines.; This spontaneous report was received from a medical assistant regarding an 6-month-old female patient. The patient's medical history, concurrent conditions, and concomitant therapies were not reported.  On a unknown date in 2023, the patient missed her 4 month well child visit to receive her rotavirus vaccine, live, oral pentavalent (ROTATEQ) and diphtheria vaccine toxoid, hepatitis b vaccine rhbsag (yeast), hib vaccine conj (menigococcal protein), pertussis vaccine acellular 5-component, polio vaccine inact 3v (vero), tetanus vaccine toxoid (VAXELIS) do (Product dose omission issue). On 27-APR-2023, she was vaccinated with rotavirus vaccine, live, oral, pentavalent (ROTATEQ) oral liquid, 2 milliliter, administered orally as prophylaxis (strength, lot #, and expiry date were not provided and diphtheria vaccine toxoid, hepatitis b vaccine rhbsag (yeast), hib vaccine conj (menigococcal protein), pertussis vaccine acellular 5-component, polio vaccine inact 3v (vero), tetanus vaccine toxoid (VAXELIS), product quantity 1, milliliter (strength, formulation, lot #, expiry date, route of administration, and indication were not provided) at he month well child check up. On 11-MAY-2023, the patient was accidentally vaccinated with another dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) oral liquid, product quantity 1, 2 milliliter, lot #1932214, expiration date: APR-2024, administered orally as prophylaxis; and diphtheria vaccine toxoid, hepatitis b vaccine rhbsag (yeast), h vaccine conj (menigococcal protein), pertussis vaccine acellular 5-component, polio vaccine inact 3v (vero), tetan vaccine toxoid (VAXELIS), product quantity 1, 0.5 milliliter, batch/lot #U7296AA, and expiration date: 26-FEB-202 (strength, formulation, route of administration, and indication were not provided) (Extra dose administered). It was reported that the patient had not experienced any adverse reactions associated with the administrations.   The causal relationship between Vaxelis and the event " On 27-APR-2023, she was vaccinated with rotavirus vaccine and Vaxelis. On 11-MAY-2023, the patient was accidentally vaccinated with another dose of rotavirus vaccine and Vaxelis was accidentally administered another dose of VAXELIS and ROTATEQ," was assessed as not applicable due to the nature of the reported event.  No further information is expected.